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Abstract
Background: Trimethoprim resistance is increasing in Enterobacteriaceae. In 2004-2006 an intervention on trimethoprim use
was conducted in Kronoberg County, Sweden, resulting in 85% reduction in trimethoprim prescriptions. We investigated
the distribution of dihydrofolate reductase (dfr)-genes and integrons in Escherichia coli and Klebsiella pneumoniae and the
effect of the intervention on this distribution.
Methodology/Principal Findings: Consecutively isolated E. coli (n=320) and K. pneumoniae (n=54) isolates phenotypicaly
resistant to trimethoprim were studied. All were investigated for the presence of dfrA1, dfrA5, dfrA7, dfrA8, dfrA12, dfrA14,
dfrA17 and integrons class I and II. Isolates negative for the seven dfr-genes (n=12) were also screened for dfr2d, dfrA3,
dfrA9, dfrA10, dfrA24 and dfrA26. These genes accounted for 96% of trimethoprim resistance in E. coli and 69% in K.
pneumoniae. The most prevalent was dfrA1 in both species. This was followed by dfrA17 in E. coli which was only found in
one K. pneumoniae isolate. Class I and II Integrons were more common in E. coli (85%) than in K. pneumoniae (57%). The
distribution of dfr-genes did not change during the course of the 2-year intervention.
Conclusions/Significance: The differences observed between the studied species in terms of dfr-gene and integron
prevalence indicated a low rate of dfr-gene transfer between these two species and highlighted the possible role of narrow
host range plasmids in the spread of trimethoprim resistance. The stability of dfr-genes, despite large changes in the
selective pressure, indirectly suggests a low fitness cost of dfr-gene carriage.
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Introduction
The increase in antibiotic resistance is a threat to global health
[1]. Trimethoprim is commonly used in the treatment of urinary
tract infections (UTI) in all parts of the world [2]. However,
already soon after the introduction of the drug, trimethoprim
resistance was reported in several species [3] and are now in
unselected UTI materials at levels of 15–65% in E. coli [4,5,6].
This leads to treatment failure and increasing workload in primary
healthcare and trimethoprim containing antibiotics are thus
questioned as first line therapy [7].
Resistance to trimethoprim is caused by modifications in the
target enzyme dihydrofolate reductase (dfr) encoded by dfr-genes.
So far 30 dfr-genes are described and they are usually associated
with integrons [3]. Integrons are integrated in transposons
predominantly located on plasmids and can insert, excise and
express mobile gene cassettes, often antibiotic resistance genes [8].
This results in an efficient horizontal spread of antibiotic resistance
between bacteria [8,9,10]. Only few studies have investigated the
epidemiology and frequency of the different dfr-genes and the
relationship to integrons and other resistance determinants in E. coli
[9,11,12]. In K. pneumoniae the distribution of dfr-genes is not known.
A two year prospective intentional intervention on the use of
trimethoprim was performed in Kronoberg County, Sweden,
from October 1
st, 2004 to September 30
th, 2006. A drastic and
sustained 85% reduction in the use of trimethoprim and
trimethoprim-sulphamethoxazole was achieved at county level.
A corresponding increase was seen in the use of nitrofurantoin,
pivmecillinam and to some extent ciprofloxacin. The effect on
trimethoprim resistance was marginal[13] explained by the low
fitness cost of trimethoprim resistance observed and the high
level of associated resistance in trimethoprim resistant isolates
[13]. During 4 years including the intervention all urinary
tract isolates of Enterobacteriaceae, both hospital and community
acquired, were stored frozen at 270uC. Using these, we investi-
gated the distribution of 13 dfr-genes and class I and II integrons
in trimethoprim resistant E. coli and K. pneumoniae. We also
investigated the associated resistance rates in these isolates and
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trimethoprim resistance within and between the two species.
Materials and Methods
Material
Three hundred and twenty (320) consecutively collected trime-
thoprim resistant E. coli isolates during three time periods were
identified. The periods were: four months before the intervention
(June to September 2004 (n=106)), one year into the intervention
(October to December 2005 (n=105)) and the last four months of
the intervention (June to September 2006 (n=109)). Within each
of the time periods duplicate patient samples were excluded. Fifty
four (54) consecutive trimethoprim resistant K. pneumoniae isolates
from June 2004 to September 2007, reflecting the relative number
of isolates of the respective pathogens in UTI, were retrieved.
Isolates were from urinary samples from hospitals and community
and from all age groups.
Methods
Susceptibility testing. Escherichia coli and K. pneumoniae
were identified according to standard procedures used in the
Department of Clinical Microbiology, Va ¨xjo ¨, Sweden, at the
time of the study. Susceptibility testing was performed using
disc diffusion on IsoSensitest Agar (Oxoid, Basingstokes, UK)
according to the Swedish Reference Group on Antibiotics (SRGA)
guidelines (http://www.srga.org/). All isolates were tested with the
following antibiotic discs (Oxoid, Basingstokes, UK) mecillinam
10 mg, ampicillin 10 mg, cefadroxil 30 mg, trimethoprim 5 mg,
nitrofurantonin 100 mg and nalidixic acid 30 mg. To obtain the
most sensitive detection of antibiotic resistance, the resistant
and susceptible populations were identified by calculating the
epidemiological cut-off values by using the Normalized inter-
pretation method (NRI) [14]. For mecillinam the SRGA R-
breakpoint used at the time of isolation was applied to avoid
false associations to TMP resistance due to concomitant AMP
resistance affecting the MEC MIC only marginally (i.e. MIC#8)
and considered not to be due to specific mecillinam resis-
tance mechanisms (Kahlmeter unpublished data). Trimethoprim
resistance was further analysed using E-test (bioMe ´rieux, Solna,
Sweden).
PCR. DNA lysates were prepared by resolving a loop full
(1 ml) of bacteria in 100 ml DNase and RNase free water (Sigma-
Aldrich, Stockholm, Sweden). The mixture was boiled for 2
minutes and the tubes were centrifuged at 13000 rpm for 2
minutes. The supernatant was stored in 220uC and used as DNA
template. All isolates, both E. coli and K. pneumoniae, were first
screened for the five most prevalent resistance genes reported in
trimethoprim resistant E. coli; dfrA1, dfrA5, dfrA7, dfrA12 and dfrA17
[9,11] using a previously published real-time multiplex PCR
protocol [15]. In addition dfrA8 and dfrA14 was screened for
among all isolates. In isolates negative to these genes (n=12) dfr2d,
dfrA3, dfrA9, dfrA10, dfrA24 and dfrA26 were analysed using
separate PCRs. Internal controls with primers for 16S rDNA was
used as template control [16]. All isolates were in addition
analyzed for the presence of integron class I and II, which are
the most common integrons associated with dfr-genes [8]. The
screening of dfr-genes and integrons class I and II was performed
using simplex PCRs, described by Grape et al [17]. The PCR for
integron class I detection was performed using two sets of primers
to avoid false negative results due to modifications in the 39CS
region. A PCR product with either of these primer pairs was
considered a positive result. Previously unpublished primers are
described in Table 1.
Semi-random PCR. Semi random PCR [18] was performed
on three E. coli isolates where the PCR only yielded an amplicon
corresponding to the 59CS (IntI1) of integron class I. Primers for
identification of resistance cassettes integrated in integron class I
were designed targeted at IntI1; 51 bp and 27 bp respectively
from the cassette region (Table 2).
Sequence analysis. Sequence analysis was performed on the
semi-random PCR amplicons as well as on two isolates where we
could only detect a complete integron class I structure (59CS-
39CS). PCR products (50 ml reactions) were purified using Jet
Quick PCR Product Purification Spin kit (Genomed, Lo ¨hne,
Germany) or, in case of unspecific PCR products, extracted from
electrophoresis gel by using the Jet Quick Gel Extraction Spin
kit (Genomed, Lo ¨hne, Germany). Sequencing reactions were
performed by using the ABI Prism Big Dye Terminator Cycle
Sequencing kit v. 3.1 (Applied Biosystems, Stockholm, Sweden)
according to manufacturer’s instructions. Sequence data was
analysed with the Sequencher software v. 4.1.4 (Gene Codes
Corporation, Ann Arbor, MI).
Ethics
As this study was based on bacterial isolates collected
from routine samples, approval from ethics committee was not
necessary. Neither was there any need for informed consent
procedures as no extra sampling was performed and no personal
data was stored in relation to the isolates.
Statistics
|
2-test was used for comparing dfr-gene prevalence and distri-
bution in E. coli and K. pneumoniae.
Results
dfr-Genes and Integrons
The total prevalence of the 13 analysed dfr-genes was 96%
(n=308) in E. coli and 69% (n=38) in K. pneumoniae. The integron
Table 1. Primers not previously published used in the PCR screenings.
Primer Locus Sequence (59-39) Annealing temperature (C) Product size (bp) Reference
dfrA14-f 59 dfrA14 CTG CGA AAG CGA AAA ACG GCG 55 376 This study
dfrA14-r 39 dfrA14 GGA ATA CTC GGG AAG AAA ACA 55 This study
dfrA24-f 59 dfrA24 CGT TGC TGC TAC TGA GAA CG 54 158 This study
dfrA24-r Mid dfrA24 TGC GGT CTT TCA GAG GAC TT 54 This study
dfrA26-f 59 dfrA26 GGT AAC GCG TCA ACA AGG TT 56 190 This study
dfrA26-r 39 dfrA26 GGC GTG TAC TTC GGT GAG AT 56 This study
doi:10.1371/journal.pone.0009233.t001
dfr in E.coli/K.pneumoniae
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57% (n=31) in E. coli and K. pneumoniae, respectively. These
differences were statistically significant (p,0.001). The most
common trimethoprim resistance gene in both investigated species
was dfrA1. The second most frequent dfr-gene in E. coli, dfrA17, was
rare in K. pneumoniae - it was found in only one isolate. The genes
dfr2d and dfrA24 were found only in E. coli and genes dfrA3 and
dfrA9 only in K. pneumoniae. Four E. coli isolates and one K.
pneumoniae isolate carried two dfr-genes. The dfrA1 gene was present
together with either dfrA5, dfrA7, dfrA14 or dfrA17 in E. coli and
together with dfrA8 in K. pneumoniae.
The prevalence of each of the 13 different dfr-genes and
integrons class I and II found in the E. coli and K. pneumoniae
isolates are presented in Table 3. No major shifts in the dfr-gene/
integron distribution were seen in the E. coli isolates during the
intervention. The K. pneumoniae collection was too small for
statistically significant changes to be detected.
In 83 E. coli isolates the integron screenings only detected the
integrase gene (59CS of the integron class I) as opposed to the
whole integron structure (59CS-39CS). In K. pneumoniae the
corresponding figure were 14 isolates. In the E. coli collection
there were eight isolates where the class I integrase but no dfr-genes
was detected. Semi-random PCR was used on these eight isolates
to seek for dfr-genes downstream from this element. This resulted
in the detection of five isolates with dfrA14. Since dfrA14 and dfrA8
appeared to be present more than we had expected we decided to
screen the whole collection of E. coli as well as K. pneumoniae for this
gene. In two E. coli isolates PCR detected the whole integron class
I structure but no dfr-genes. The integron class I was then
sequenced and found to include dfrA1. The dfrA1-gene in these
isolates had mutations in the reverse primer binding site, which is
probably why they were not found with the multiplex PCR
analysis. After these analyses 10 out of 320 E. coli isolates ended up
having an unknown genetic background of trimethoprim resis-
tance. Seven of these were integron class I and II negative. In the
K. pneumoniae collection 17 out of 54 isolates were negative for the
dfr-genes analysed and 14 of these were negative for the integrons
investigated. The relationship between the dfr-genes studied and
integron prevalence in E. coli and K. pneumoniae is described in
Table 4. Class II integrons are known to be conserved and always
includes dfrA1, which was also the case in these investigated
isolates. No integrons were detected in isolates positive for dfr2d
and dfrA9.
Resistance Phenotypes
All isolates were tested for susceptibility to antibiotics commonly
used in the treatment of UTI. As expected, the prevalence of
integrons was high in the material and the probability of integron
Table 2. Primers not previously published used in the semi random PCR and sequence analysis.
Primer Locus Sequence (59-39)
Annealing
temperature (C) Product size (bp) Reference
IntI1-f 59 CS class 1 integrons
51 bp from casette region
TAC GCC GTG GGT
CGA TGT TTG ATG
64 Depend on where
Arb1 or 6 binds
[24]
IntI1-s 59 CS class 1 integrons
27 bp from casette region
TTA TGG AGC AGC
AAC GAT GT
50 Depend on where
Arb1 or 6 binds
This study
doi:10.1371/journal.pone.0009233.t002
Table 3. No. of isolates positive for the investigated dfr-genes and integrons in E. coli (n=320) and K. pneumoniae (n=54) collected
at time periods before and during the trimethoprim intervention.
E. coli K. pneumoniae
Pre intervention
n=106
Mid intervention
n=105
Post intervention
n=109
Total
n=320 (%)
Total
n=55 (%)
dfrA1 36 41 33 110(34) 8 (15)
dfr2d 1 0 0 1(0.3) 0
dfrA3 00 00 1 ( 2 )
dfrA5 17 17 18 52(16) 7 (13)
dfrA7 3 7 5 15(5) 1 (2)
dfrA8 3 3 8 14(4) 7 (13)
dfrA9 00 00 1 ( 2 )
dfrA10 00 00 0
dfrA12 62 61 4 ( 4 ) 7 ( 1 3 )
dfrA14 94 61 9 ( 6 ) 5 ( 9 )
dfrA17 26 29 27 82 (26) 1 (2)
dfrA24 1 0 0 1 (0.3) 0
dfrA26 00 00 0
Integron 1 75 74 82 230 (72) 29 (53)
Integron 2 10 19 14 43 (13) 2 (4)
doi:10.1371/journal.pone.0009233.t003
dfr in E.coli/K.pneumoniae
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(Table 5 and 6). High levels of associated resistance have been
described previously in trimethoprim resistant isolates [19]. In the
present material ampicillin resistance was 78% and nalidixic acid
resistance was 26% in trimethoprim resistant E. coli. Most dfr-genes
were equally associated to these phenotypic resistances but dfrA8
was only associated with ampicillin resistance in E. coli.
Discussion
Although common, the epidemiology of trimethoprim resis-
tance in other species than E. coli has not been well studied at
the molecular level. Recently we performed a highly controlled
intervention on trimethoprim use in Kronoberg County, Sweden.
Despite a drastic decrease (85%) in trimethoprim consumption
the effect on the rate of trimethoprim resistance in E. coli was
disappointingly marginal [13]. This was explained by co-selection
mediated by a high level of associated resistance in trimethoprim
resistant isolates and by a low fitness cost conferred by trime-
thoprim resistance measured in vitro in clinical isolates of E. coli
[13]. The clonal distribution in E. coli remained unaffected [13].
The present study shows a lack of effect on the overall distribution
of dfr-genes (Table 3). It also compares the distribution of dfr-genes
in E. coli and K. pneumoniae.
The overall prevalence of the different dfr-genes in E. coli was
in line with earlier studies performed in different clinical and
geographical settings by, amongst others, Blahna [9] and Lee. [11]
These studies have indicated a very stable distribution of dfr-genes
over time with dfrA1 and dfrA17 as the most prevalent genes. The
stability over time and throughout the intervention suggests that
the epidemiological fitness cost of the most common dfr-genes or of
plasmids carrying these genes is very low. The fact that dfrA8 and
dfrA14 were as common as dfrA7 and dfrA12 indicates possible
future shifts in the dfr-gene distribution. So far dfrA3, dfrA8, dfrA9,
dfrA10 and dfrA24 have not been reported as cassettes in integron
structures [20]. Multiple dfr-genes occur but are unusual. The
PCR screening performed for dfrA1, dfrA5, dfrA7, dfrA8, dfrA12,
dfrA14 and dfrA17 detected coexistence of two genes in four out of
320 E. coli isolates and one out of 54 K. pneumoniae isolates. Previous
studies also confirm this; in a large European study [9] they found
multiple dfr-genes in two out of 163 trimethoprim resistant isolates
and in a Korean study [11] the same figure was three out of 77
trimethoprim resistant isolates. Based on this we decided to screen
for the additional six dfr-genes in the trimethoprim resistant
isolates that were negative in the multiplex PCR analysis.
The prevalence of dfr-genes and integrons in K. pneumoniae has
not been studied systematically before and was surprisingly
different from E. coli. The low prevalence of integrons class I
and II could suggest other mechanisms at play or that transfer of
dfr-genes in K. pneumoniae does not occur. The genes dfrA5, dfrA8
and dfrA12 were more common in K. pneumoniae than in E. coli and
dfrA17, being the second most frequent dfr-gene in E. coli, was only
found in a single K. pneumoniae isolate. Recent studies in mice
showed that plasmids carrying varying resistance genes were easily
transferred from an E. coli donor to K. pneumoniae in a mouse
model. [21] Our data, showing a pronounced disproportion in the
prevalence of integrons and dfr-genes in E. coli and K. pneumoniae,
speak to the opposite. This could be because dfr-genes are carried
on narrow host range plasmids, or are integrated in the chro-
Table 4. The relationship between dfr-genes and integron
class I and II in E. coli (n=320) and K. pneumoniae (n=54).
E. coli No. No. K. pneumoniae No. No.
Igr1 Igr2 Igr1 Igr2
dfrA1
a 61 44 dfrA1
b 52
dfr2d 00dfr2d 00
dfrA3 00dfrA3 10
dfrA5 49 0 dfrA5 70
dfrA7 15 0 dfrA7 10
dfrA8 10dfrA8 10
dfrA9 00dfrA9 00
dfrA10 00dfrA10 00
dfrA12 12 0 dfrA12 70
dfrA14 80dfrA14 40
dfrA17 81 0 dfrA17 10
dfrA24 10dfrA24 00
dfrA26 00dfrA26 00
All dfr+ 228 44 All dfr+ 27 2
aIncluding 10 isolates positive for both Igr1 and 2.
bIncluding one isolate positive for both Igr 1 and 2.
doi:10.1371/journal.pone.0009233.t004
Table 5. No. of E. coli (n=320) isolates resistant to
trimethoprim only and in combination with other antibiotics
and in relation to the presence of integrons.
Resistance phenotype isolates (#) Integron (%)
TMP (only) 58 71
TMP, AMP 66 61
TMP, NAL 13 69
TMP, AMP, NAL 56 91
TMP, AMP, MEC 10 90
TMP, AMP, CFR 3 100
TMP, NAL, CFR 1 100
TMP, AMP, NAL, CFR 8 100
TMP, AMP, NAL, NIT 5 80
TMP, AMP, NAL, MEC 1 100
TMP=trimethoprim, AMP=ampicillin, NAL=nalidixic acid, MEC=mecillinam,
CFR=cefadroxil and NIT=nitrofurantoin.
doi:10.1371/journal.pone.0009233.t005
Table 6. No. of K. pneumoniae (n=54) isolates resistant to
trimethoprim only and in combination with other antibiotics
and in relation to the presence of integrons.
Resistance phenotype isolates (#) Integron (%)
TMP, AMP, NIT 27 67
TMP, AMP, NIT, MEC 2 0
TMP, AMP, NIT, NAL 18 39
TMP, AMP, NIT, MEC, NAL 5 40
TMP, AMP, NIT, CFR, MEC 1 100
TMP, AMP, NIT, CFR, NAL 1 100
TMP=trimethoprim, AMP=ampicillin, NAL=nalidixic acid, MEC=mecillinam,
CFR=cefadroxil and NIT=nitrofurantoin.
doi:10.1371/journal.pone.0009233.t006
dfr in E.coli/K.pneumoniae
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dfr-genes in E. coli and K. pneumoniae. The trimethoprim resistant K.
pneumoniae were collected over three years, from individuals of all
age groups and varying residency. The K. pneumoniae isolates were
not typed but with this background clonal spread of these isolates
seems an unlikely explanation for the observed differences between
E. coli and K. pneumoniae.
Trimethoprim resistance is often associated with other resis-
tance determinants. [8,9,17,22] This gives the possibility for co-
selection of trimethoprim resistant strains and plasmids carrying
both dfr-genes as well as other resistance determinants by the use of
other antibiotic classes. In this study no striking difference in the
distribution of other resistance determinants in relation to specific
dfr-genes was seen. The only exception was E. coli isolates carrying
dfrA8 (n=10) where an association exclusively with ampicillin
resistance were found. Only one out of ten of these isolates carried
an integron class I. As a bright contrast, dfrA17 was found to be
associated with resistance to all investigated antibiotics and 81 out
of 82 isolates also carried an integron class I. The association of the
dfr-genes studied and quinolone resistance is to be explained by co-
existence in the same isolates rather than association on fellow
plasmids as the frequency of plasmid associated quinolone
resistance genes (qnr and aac(69)-Ib-cr) in our area is very low
[23]. These findings suggests some lineages in E. coli to be better
suited to acquire and stabilize antibiotic resistance determinants
and reveals a need for future studies to understand the associa-
tions between plasmids, integrons, gene-cassettes and the genetic
backbone.
In conclusion, trimethoprim resistance in E. coli was explained
almost entirely by the 13 investigated dfr-genes. These isolates
were also to a large extent positive for integrons class I and/or II.
The distribution of dfr-genes in E. coli was in line with earlier
published data and remained stable throughout the intervention.
In K. pneumoniae we observed a low prevalence of the most common
dfr-genes in E. coli and a surprisingly low rate of integron class I
and II. This indicates that the exchange of dfr-genes between E. coli
and K. pneumoniae may be an uncommon event in man. These
results suggest the need for more studies on the genetic context of
dfr-genes and their location in or association with mobile genetic
elements and other resistance genes as well as their association to
certain plasmid types. It reminds us that we can not only rely on
model organisms, such as E. coli, to understand the variety of
phenotypic resistance.
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